Just Earth News | @justearthnews | 04 May 2021, 01:20 am Print
Pfizer-BioNTech Image: Pixabay
Washinton/Sputnik: The US Food and Drug Administration (FDA) is preparing to approve the Pfizer-BioNTech COVID-19 vaccine for those aged 12 to 15, The New York Times reported, citing federal officials.
The authorization is expected to come early next week, the report said on Monday.
Pfizer announced several weeks ago that none of the adolescents who have received the vaccine during trials have contracted a symptomatic case of COVID-19.
However, plans to vaccinate teens and children, who rarely contract serious cases of the illness, have sparked debate, the report added, as many question whether excess US vaccines could be put to better use on adults in other countries.
- Global obesity crisis deepens: One in five kids now overweight, study highlights
- Alarming projection: Global breast cancer cases could cross 3.5 million by 2050, shows study
- Exam stress to emotional distress: Study reveals the dark side of academic pressure
- Vegetarian diet linked to lower risk of five major cancers, study finds
- Ukraine’s health system under fire: Attacks spike 20% in 2025, WHO warns
-1763561110.jpg "Image of the day: November 19, 2025")
